KJIM :: Korean Journal of Internal Medicine

KRAS as a Prognostic and Predictive Marker in Metastatic Non-Small Cell Lung Carcinoma: A Systematic Review

Sheereen Fatima, Nirav Pansuriya, Alisha Lakhani, Sai Madhuri, Reshma Ajmal, Ruchira Clementina, Zahabiya Lakdawala, Kinjal Shah, Husna Dilshana, Maya Andrea, Bejoi Mathew, Aashna Raheja

MYC and KRAS cooperation: from historical challenges to therapeutic opportunities in cancer

Sílvia Casacuberta-Serra, Íñigo González-Larreategui, Daniel Capitán-Leo, Laura Soucek

Signal Transduction and Targeted Therapy.2024;[Epub] CrossRef

LncRNA-NEAT1 facilitates autophagy to boost pemetrexed resistance in lung adenocarcinoma via the mir-379-3p/HIF1A pathway

Human & Experimental Toxicology.2024;[Epub] CrossRef

WITHDRAWN: Oncogenic lncRNA MALAT-1 recruits E2F1 to upregulate RAD51 expression and thus promotes cell autophagy and tumor growth in non-small cell lung cancer

Pulmonary Pharmacology & Therapeutics.2023; : 102199. CrossRef

A Critical Review of the Prognostic and Predictive Implications of KRAS and STK11 Mutations and Co-Mutations in Metastatic Non-Small Lung Cancer

Journal of Personalized Medicine.2023; 13(6): 1010. CrossRef

Therapeutic Outcomes and Clinical Features of Advanced Non–Small Cell Lung Cancer Carrying KRAS Mutations: A Multicenter Real-life Retrospective Study

Giulia Mazzaschi, Fabiana Perrone, Roberta Minari, Michela Verzè, Cinzia Azzoni, Lorena Bottarelli, Monica Pluchino, Maria Pia Armillotta, Annalisa Ubaldi, Annalisa Altimari, Elisa Gruppioni, Francesca Sperandi, Elisa Andrini, Giorgia Guaitoli, Stefania B

Definitive Chemoradiation and Durvalumab Consolidation for Locally Advanced, Unresectable KRAS-mutated Non-Small Cell Lung Cancer

Matthew Z. Guo, Joseph C. Murray, Paola Ghanem, K Ranh Voong, Russell K. Hales, David Ettinger, Vincent K. Lam, Christine L. Hann, Patrick M. Forde, Julie R. Brahmer, Benjamin P. Levy, Josephine L. Feliciano, Kristen A. Marrone

Molecular Biology and Therapeutic Perspectives for K-Ras Mutant Non-Small Cell Lung Cancers

Elona Cekani, Samantha Epistolio, Giulia Dazio, Marco Cefalì, Luciano Wannesson, Milo Frattini, Patrizia Froesch

Light at the end of the tunnel: Clinical features and therapeutic prospects of KRAS mutant subtypes in non-small-cell lung cancer

Prognostic Value of KRAS Mutation Subtypes and PD-L1 Expression in Patients With Lung Adenocarcinoma

Luwei Tao, Ruoyu Miao, Tarek Mekhail, Jingxin Sun, Lingbin Meng, Cheng Fang, Jian Guan, Akriti Jain, Yuan Du, Amanda Allen, Brenda L. Rzeszutko, Mark A. Socinski, Chung-Che Chang

KRAS G12C-mutated advanced non-small cell lung cancer: A real-world cohort from the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315)

Martin Sebastian, Wilfried E.E. Eberhardt, Petra Hoffknecht, Martin Metzenmacher, Thomas Wehler, Konrad Kokowski, Jürgen Alt, Wolfgang Schütte, Reinhard Büttner, Lukas C. Heukamp, Albrecht Stenzinger, Martina Jänicke, Annette Fleitz, Stefan Zacharias, Ste

Retrospective Comparative Analysis of KRAS G12C vs. Other KRAS Mutations in mCRC Patients Treated With First-Line Chemotherapy Doublet + Bevacizumab

Riccardo Giampieri, Alessio Lupi, Pina Ziranu, Alessandro Bittoni, Andrea Pretta, Federica Pecci, Mara Persano, Enrica Giglio, Cecilia Copparoni, Sonia Crocetti, Alessandra Mandolesi, Gavino Faa, Pierpaolo Coni, Mario Scartozzi, Rossana Berardi

Expression of PD-1/PD-L1 in lung adenocarcinoma and its clinical significance*

Oncology and Translational Medicine.2021; 7(1): 15. CrossRef

Clinical outcomes to pemetrexed-based versus non-pemetrexed-based platinum doublets in patients with KRAS-mutant advanced non-squamous non-small cell lung cancer

B. Ricciuti, M. Brambilla, A. Cortellini, A. De Giglio, C. Ficorella, A. Sidoni, G. Bellezza, L. Crinò, V. Ludovini, S. Baglivo, G. Metro, R. Chiari

Clinical and Translational Oncology.2020; 22(5): 708. CrossRef

A Real-World Study in Advanced Non–Small Cell Lung Cancer with KRAS Mutations

Lei Lei, Wen-xian Wang, Zong-yang Yu, Xian-bin Liang, Wei-wei Pan, Hua-fei Chen, Li-ping Wang, Yong Fang, Min Wang, Chun-wei Xu, Mei-yu Fang

Translational Oncology.2020; 13(2): 329. CrossRef

Notch Transduction in Non-Small Cell Lung Cancer

Amnah Sharif, Ann Shaji, May Chammaa, Eileen Pawlik, Rodrigo Fernandez-Valdivia

International Journal of Molecular Sciences.2020; 21(16): 5691. CrossRef

New Horizons in KRAS-Mutant Lung Cancer: Dawn After Darkness

Haitang Yang, Shun-Qing Liang, Ralph A. Schmid, Ren-Wang Peng

Drug Resistance in Non-Small Cell Lung Cancer: A Potential for NOTCH Targeting?

Venus Sosa Iglesias, Lorena Giuranno, Ludwig J. Dubois, Jan Theys, Marc Vooijs

Management of KRAS-Mutant Non-Small Cell Lung Cancer in the Era of Precision Medicine

Current Treatment Options in Oncology.2018;[Epub] CrossRef

Realities of KRAS-mutated non-small cell lung cancer

The Korean Journal of Internal Medicine.2017; 32(3): 442. CrossRef